SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-268019
Filing Date
2020-10-13
Accepted
2020-10-13 08:46:02
Documents
14
Period of Report
2020-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d31922d8k.htm   iXBRL 8-K 35319
2 EX-3.1 d31922dex31.htm EX-3.1 6170
3 EX-3.2 d31922dex32.htm EX-3.2 150014
  Complete submission text file 0001193125-20-268019.txt   356822

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA akca-20201012.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20201012_lab.xml EX-101.LAB 19639
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20201012_pre.xml EX-101.PRE 12310
7 EXTRACTED XBRL INSTANCE DOCUMENT d31922d8k_htm.xml XML 3654
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 201234766
SIC: 2834 Pharmaceutical Preparations